A randomized study of chemotherapy versus biochemistry with chemotherapy plus aloe arborescens in patients with metastatic cancer

Paolo Lissoni, Franco Rovelli, Fernando Brivio, Romano Zago, Massimo Colciago, Giuseppina Messina, Adelio Mora, Giorgio Porro

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background: The recent advances in the analysis of tumor immunobiology suggest the possibility of biologically manipulating the efficacy and toxicity of cancer chemotherapy by endogenous or exogenous immunomodulating substances. Aloe is one of the of the most important plants exhibiting anticancer activity and its antineoplastic property is due to at least three different mechanisms, based on antiproliferative, immunostimulatory and antioxidant effects. The antiproliferative action is determined by anthracenic and antraquinonic molecules, while the immunostimulating activity is mainly due to acemannan. Patients and Methods: A study was planned to include 240 patients with metastatic solid tumor who were randomized to receive chemotherapy with or without Aloe. According to tumor histotype and clinical status, lung cancer patients were treated with cisplatin and etoposide or weekly vinorelbine, colorectal cancer patients received oxaliplatin plus 5-fluorouracil (5-FU), gastric cancer patients were treated with weekly 5-FU and pancreatic cancer patients received weekly gemcitabine. Aloe was given orally at 10 ml thrice/daily. Results: The percentage of both objective tumor regressions and disease control was significantly higher in patients concomitantly treated with Aloe than with chemotherapy alone, as well as the percent of 3-year survival patients. Conclusion: This study seems to suggest that Aloe may be successfully associated with chemotherapy to increase its efficacy in terms of both tumor regression rate and survival time.

Original languageEnglish
Pages (from-to)171-176
Number of pages6
JournalIn Vivo
Volume23
Issue number1
Publication statusPublished - Jan 2009

Fingerprint

Aloe
Biochemistry
Chemotherapy
Tumors
Drug Therapy
oxaliplatin
Neoplasms
gemcitabine
Fluorouracil
Disease control
Etoposide
Antineoplastic Agents
Cisplatin
Toxicity
Antioxidants
Pancreatic Neoplasms
Molecules
Stomach Neoplasms
Colorectal Neoplasms
Lung Neoplasms

Keywords

  • Aloe
  • Biochemotherapy
  • Natural cancer therapy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Cite this

Lissoni, P., Rovelli, F., Brivio, F., Zago, R., Colciago, M., Messina, G., ... Porro, G. (2009). A randomized study of chemotherapy versus biochemistry with chemotherapy plus aloe arborescens in patients with metastatic cancer. In Vivo, 23(1), 171-176.

A randomized study of chemotherapy versus biochemistry with chemotherapy plus aloe arborescens in patients with metastatic cancer. / Lissoni, Paolo; Rovelli, Franco; Brivio, Fernando; Zago, Romano; Colciago, Massimo; Messina, Giuseppina; Mora, Adelio; Porro, Giorgio.

In: In Vivo, Vol. 23, No. 1, 01.2009, p. 171-176.

Research output: Contribution to journalArticle

Lissoni, P, Rovelli, F, Brivio, F, Zago, R, Colciago, M, Messina, G, Mora, A & Porro, G 2009, 'A randomized study of chemotherapy versus biochemistry with chemotherapy plus aloe arborescens in patients with metastatic cancer', In Vivo, vol. 23, no. 1, pp. 171-176.
Lissoni, Paolo ; Rovelli, Franco ; Brivio, Fernando ; Zago, Romano ; Colciago, Massimo ; Messina, Giuseppina ; Mora, Adelio ; Porro, Giorgio. / A randomized study of chemotherapy versus biochemistry with chemotherapy plus aloe arborescens in patients with metastatic cancer. In: In Vivo. 2009 ; Vol. 23, No. 1. pp. 171-176.
@article{057b215da5b24b438c2e23f798c27ce3,
title = "A randomized study of chemotherapy versus biochemistry with chemotherapy plus aloe arborescens in patients with metastatic cancer",
abstract = "Background: The recent advances in the analysis of tumor immunobiology suggest the possibility of biologically manipulating the efficacy and toxicity of cancer chemotherapy by endogenous or exogenous immunomodulating substances. Aloe is one of the of the most important plants exhibiting anticancer activity and its antineoplastic property is due to at least three different mechanisms, based on antiproliferative, immunostimulatory and antioxidant effects. The antiproliferative action is determined by anthracenic and antraquinonic molecules, while the immunostimulating activity is mainly due to acemannan. Patients and Methods: A study was planned to include 240 patients with metastatic solid tumor who were randomized to receive chemotherapy with or without Aloe. According to tumor histotype and clinical status, lung cancer patients were treated with cisplatin and etoposide or weekly vinorelbine, colorectal cancer patients received oxaliplatin plus 5-fluorouracil (5-FU), gastric cancer patients were treated with weekly 5-FU and pancreatic cancer patients received weekly gemcitabine. Aloe was given orally at 10 ml thrice/daily. Results: The percentage of both objective tumor regressions and disease control was significantly higher in patients concomitantly treated with Aloe than with chemotherapy alone, as well as the percent of 3-year survival patients. Conclusion: This study seems to suggest that Aloe may be successfully associated with chemotherapy to increase its efficacy in terms of both tumor regression rate and survival time.",
keywords = "Aloe, Biochemotherapy, Natural cancer therapy",
author = "Paolo Lissoni and Franco Rovelli and Fernando Brivio and Romano Zago and Massimo Colciago and Giuseppina Messina and Adelio Mora and Giorgio Porro",
year = "2009",
month = "1",
language = "English",
volume = "23",
pages = "171--176",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "1",

}

TY - JOUR

T1 - A randomized study of chemotherapy versus biochemistry with chemotherapy plus aloe arborescens in patients with metastatic cancer

AU - Lissoni, Paolo

AU - Rovelli, Franco

AU - Brivio, Fernando

AU - Zago, Romano

AU - Colciago, Massimo

AU - Messina, Giuseppina

AU - Mora, Adelio

AU - Porro, Giorgio

PY - 2009/1

Y1 - 2009/1

N2 - Background: The recent advances in the analysis of tumor immunobiology suggest the possibility of biologically manipulating the efficacy and toxicity of cancer chemotherapy by endogenous or exogenous immunomodulating substances. Aloe is one of the of the most important plants exhibiting anticancer activity and its antineoplastic property is due to at least three different mechanisms, based on antiproliferative, immunostimulatory and antioxidant effects. The antiproliferative action is determined by anthracenic and antraquinonic molecules, while the immunostimulating activity is mainly due to acemannan. Patients and Methods: A study was planned to include 240 patients with metastatic solid tumor who were randomized to receive chemotherapy with or without Aloe. According to tumor histotype and clinical status, lung cancer patients were treated with cisplatin and etoposide or weekly vinorelbine, colorectal cancer patients received oxaliplatin plus 5-fluorouracil (5-FU), gastric cancer patients were treated with weekly 5-FU and pancreatic cancer patients received weekly gemcitabine. Aloe was given orally at 10 ml thrice/daily. Results: The percentage of both objective tumor regressions and disease control was significantly higher in patients concomitantly treated with Aloe than with chemotherapy alone, as well as the percent of 3-year survival patients. Conclusion: This study seems to suggest that Aloe may be successfully associated with chemotherapy to increase its efficacy in terms of both tumor regression rate and survival time.

AB - Background: The recent advances in the analysis of tumor immunobiology suggest the possibility of biologically manipulating the efficacy and toxicity of cancer chemotherapy by endogenous or exogenous immunomodulating substances. Aloe is one of the of the most important plants exhibiting anticancer activity and its antineoplastic property is due to at least three different mechanisms, based on antiproliferative, immunostimulatory and antioxidant effects. The antiproliferative action is determined by anthracenic and antraquinonic molecules, while the immunostimulating activity is mainly due to acemannan. Patients and Methods: A study was planned to include 240 patients with metastatic solid tumor who were randomized to receive chemotherapy with or without Aloe. According to tumor histotype and clinical status, lung cancer patients were treated with cisplatin and etoposide or weekly vinorelbine, colorectal cancer patients received oxaliplatin plus 5-fluorouracil (5-FU), gastric cancer patients were treated with weekly 5-FU and pancreatic cancer patients received weekly gemcitabine. Aloe was given orally at 10 ml thrice/daily. Results: The percentage of both objective tumor regressions and disease control was significantly higher in patients concomitantly treated with Aloe than with chemotherapy alone, as well as the percent of 3-year survival patients. Conclusion: This study seems to suggest that Aloe may be successfully associated with chemotherapy to increase its efficacy in terms of both tumor regression rate and survival time.

KW - Aloe

KW - Biochemotherapy

KW - Natural cancer therapy

UR - http://www.scopus.com/inward/record.url?scp=63049128125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63049128125&partnerID=8YFLogxK

M3 - Article

C2 - 19368145

AN - SCOPUS:63049128125

VL - 23

SP - 171

EP - 176

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 1

ER -